Self-reported symptom severity, general health, and impairment in post-acute phases of COVID-19: retrospective cohort study of Swedish public employees

[1]  Jill P. Pell,et al.  Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study , 2022, Nature Communications.

[2]  K. Khunti,et al.  Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study , 2022, Open forum infectious diseases.

[3]  J. Rosmalen,et al.  Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study , 2022, The Lancet.

[4]  Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 , 2022, The Journal of Emergency Medicine.

[5]  C. Steves,et al.  Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 , 2022, The Lancet.

[6]  T. Chun,et al.  A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings , 2022, Annals of Internal Medicine.

[7]  K. Khunti,et al.  Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study , 2022, BMJ.

[8]  C. Chen,et al.  Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review , 2022, The Journal of infectious diseases.

[9]  S. Riley,et al.  Persistent COVID-19 symptoms in a community study of 606,434 people in England , 2022, Nature Communications.

[10]  E. Lundevaller,et al.  Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study , 2022, BMJ.

[11]  R. Mägi,et al.  Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study , 2022, The Lancet Public Health.

[12]  J. Cervilla,et al.  Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study , 2022, BMC Medicine.

[13]  L. Daines,et al.  Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms , 2022, Pathogens.

[14]  J. Quint,et al.  GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study , 2021, BMJ.

[15]  L. Wain,et al.  Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study , 2021, medRxiv.

[16]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[17]  G. Severi,et al.  Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. , 2021, JAMA internal medicine.

[18]  K. Telle,et al.  Impacts of mild COVID-19 on elevated use of primary and specialist health care services: A nationwide register study from Norway , 2021, PloS one.

[19]  G. Poudel,et al.  Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection , 2021, JAMA network open.

[20]  J. Geddes,et al.  Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 , 2021, PLoS medicine.

[21]  K. Telle,et al.  Impacts of mild and severe COVID-19 on sick leave , 2021, International journal of epidemiology.

[22]  A. J. van ‘t Hul,et al.  Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID Support Groups , 2021, Journal of medical Internet research.

[23]  K. T. Kalleberg,et al.  Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study , 2021, PloS one.

[24]  Adam W. Gaffney.  The Long COVID Conundrum , 2021, The American Journal of Medicine.

[25]  Ting Yu,et al.  1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.

[26]  K. Blennow,et al.  Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up , 2021, EBioMedicine.

[27]  Ryan J. Low,et al.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2021, EClinicalMedicine.

[28]  H. Bartsch,et al.  Long COVID in a prospective cohort of home-isolated patients , 2021, Nature Medicine.

[29]  A. Sarker,et al.  Long COVID symptoms from Reddit: Characterizing post-COVID syndrome from patient reports , 2021, medRxiv.

[30]  S. Ladhani,et al.  Causation or confounding: why controls are critical for characterizing long COVID , 2021, Nature Medicine.

[31]  Hanna C. Persson,et al.  Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort , 2021, BMC Public Health.

[32]  J. Bonde,et al.  Day-by-day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized healthcare workers: A 90-day follow-up study , 2021, International Journal of Infectious Diseases.

[33]  Kevin N. Heath,et al.  Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study , 2021, BMJ.

[34]  Michael Hittle,et al.  Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 , 2021, The Journal of Emergency Medicine.

[35]  B. Guery,et al.  Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study , 2021, Journal of General Internal Medicine.

[36]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[37]  M. Brady,et al.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study , 2021, BMJ Open.

[38]  H. Ullum,et al.  Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients , 2021, Scientific Reports.

[39]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[40]  P. Weihe,et al.  Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  N. Washington,et al.  Long-term COVID-19 symptoms in a large unselected population , 2020 .

[42]  F. Callard,et al.  How and why patients made Long Covid , 2020, Social Science & Medicine.

[43]  M. Spruit,et al.  Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? , 2020, ERJ Open Research.

[44]  M. Hjermstad,et al.  Symptoms in the general Norwegian adult population - prevalence and associated factors , 2020, BMC Public Health.

[45]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[46]  R. Irizarry.  ggplot2 , 2019, Introduction to Data Science.

[47]  B. Ljótsson,et al.  The 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 Administered Via the Internet to Individuals With Anxiety and Stress Disorders: A Psychometric Investigation Based on Data From Two Clinical Trials , 2017, JMIR mental health.

[48]  K. Petrie,et al.  How common are symptoms? Evidence from a New Zealand national telephone survey , 2014, BMJ Open.

[49]  S. Hutchinson,et al.  Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. , 2013, Journal of hepatology.

[50]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[51]  M. Avendano,et al.  Self-reported health assessments in the 2002 World Health Survey: how do they correlate with education? , 2010, Bulletin of the World Health Organization.

[52]  Gavin Andrews,et al.  Normative Data for the 12 Item WHO Disability Assessment Schedule 2.0 , 2009, PloS one.

[53]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[54]  O. Dalgard,et al.  Health‐related quality of life in active injecting drug users with and without chronic hepatitis C virus infection , 2004, Hepatology.

[55]  D. Jolley,et al.  The impact of diagnosis of hepatitis C virus on quality of life , 1999, Hepatology.

[56]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[57]  OUP accepted manuscript , 2022, The Journal of Infectious Diseases.

[58]  G. Poudel,et al.  Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review , 2021 .

[59]  J. Routy,et al.  Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation , 2019, Medicine.

[60]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[61]  Marta Elena Losa-Iglesias,et al.  Footwear used by older people and a history of hyperkeratotic lesions on the foot , 2017, Medicine.

[62]  藤倉雄二,et al.  わが国における成人市中肺炎の原因微生物の変遷(Meta‐analysis and systematic review) , 2017 .

[63]  T. B. Üstün,et al.  Measuring health and disability : manual for WHO Disability Assessment Schedule : WHODAS 2.0 , 2010 .

[64]  Gunnel Boström,et al.  Syfte och bakgrund till frågorna i nationella folkhälsoenkäten , 2008 .

[65]  R. Fry,et al.  COVID-19 Infection Risk amongst 14,104 Vaccinated Care Home Residents: A national observational longitudinal cohort study in Wales, United Kingdom, December 2020 to March 2021 , 2021, medRxiv.

[66]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .